Hui Miao

Director/Board Member at Beijing Zhendong Langdi Pharmaceutical Co., Ltd.

49 year

Health Technology

Consumer Services

Profile

Hui Miao is currently the Director at Beijing Zhendong Langdi Pharmaceutical Co., Ltd.
Prior to this, Mr. Miao served as the President, Chief Executive Officer & Director at GuangYuYuan Chinese Herbal Medicine Co., Ltd.
from 2022 to 2024.
Mr. Miao completed their undergraduate degree at Renmin University of China.

Hui Miao active positions

Companies	Position	Start
Beijing Zhendong Langdi Pharmaceutical Co., Ltd. Beijing Zhendong Langdi Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Part of Fountainvest Partners (Asia) Ltd., Beijing Zhendong Langdi Pharmaceutical Co., Ltd. manufactures medicinal chemicals and botanical products. The company is based in Beijing, China. Beijing Zhendong Langdi Pharmaceutical Co. was acquired by Shanghai Fanglang Enterprise Management Co. Ltd. from Shanxi Zhendong Pharmaceutical Co., Ltd. on October 28, 2021 for $895.09 million. The Chinese company was founded in 2003.	Director/Board Member	-

All active positions of Hui Miao

Former positions of Hui Miao

Companies	Position	End
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	Chief Executive Officer	09/04/2024

See the detail of Hui Miao's experience

Training of Hui Miao

Renmin University of China

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hui Miao's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	Health Technology

Private companies	1
Beijing Zhendong Langdi Pharmaceutical Co., Ltd. Beijing Zhendong Langdi Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Part of Fountainvest Partners (Asia) Ltd., Beijing Zhendong Langdi Pharmaceutical Co., Ltd. manufactures medicinal chemicals and botanical products. The company is based in Beijing, China. Beijing Zhendong Langdi Pharmaceutical Co. was acquired by Shanghai Fanglang Enterprise Management Co. Ltd. from Shanxi Zhendong Pharmaceutical Co., Ltd. on October 28, 2021 for $895.09 million. The Chinese company was founded in 2003.	Health Technology